Source: ALSCG Blog

ALSCG Blog Brexit and Parallel Imports-the end of an era?

A Pricentric Brief by Sean Skulski "In short, parallel imports of medicines into the UK provide both certainty of supply, when there is not enough UK stock (because of a sudden spike in demand), and incentivized purchasing competition which saves the NHS over £100m per annum, on current estimates." - Healthcare Distribution Association UK Council [...]The post Brexit and Parallel Imports-the end of an era? appeared first on Alliance Life Sciences.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Emmanuel Doe's photo - CEO of Alliance Life Sciences Consulting Group, Inc.

CEO

Emmanuel Doe

CEO Approval Rating

61/100

Read more